Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ganciclovir

A guanosine nucleoside analogue antiviral, patented in 1980 and approved in the late 1980s; it is used mainly against cytomegalovirus infections in people with weakened immune defences, such as transplant recipients. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?In biology it works as an "off switch": cells engineered to make the herpes virus thymidine kinase die when given ganciclovir, while normal cells cannot activate it efficiently.

GanciclovirGo to the active ingredient →
GanciclovirActive ingredientGanciclovirCat. No. P-G016-001CAS 82410-32-0
Ganciclovir-d5Isotopically labelledGanciclovir-d5Cat. No. P-G016-011CAS 1189966-73-1

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.